Sean E. Aeder

Array ( [id] => 6196120 [patent_doc_number] => 20110027878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'RANDOM HOMOZYGOUS GENE PERTURBATION TO ENHANCE ANTIBODY PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/777417 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 5083 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027878.pdf [firstpage_image] =>[orig_patent_app_number] => 12777417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6185006 [patent_doc_number] => 20110123987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS' [patent_app_type] => utility [patent_app_number] => 12/778029 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 78249 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 51 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123987.pdf [firstpage_image] =>[orig_patent_app_number] => 12778029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8796664 [patent_doc_number] => 08435531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response' [patent_app_type] => utility [patent_app_number] => 12/775300 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 14926 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12775300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608597 [patent_doc_number] => 07993852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'MN/CA IX and cancer prognosis' [patent_app_type] => utility [patent_app_number] => 12/774158 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 14099 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993852.pdf [firstpage_image] =>[orig_patent_app_number] => 12774158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503272 [patent_doc_number] => 08741581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Markers for cancer detection' [patent_app_type] => utility [patent_app_number] => 13/266567 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 33185 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234884 [patent_doc_number] => 20100266588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Breast Cancer Susceptibility Gene GT198 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/763483 [patent_app_country] => US [patent_app_date] => 2010-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15858 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266588.pdf [firstpage_image] =>[orig_patent_app_number] => 12763483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11872435 [patent_doc_number] => 09744184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-29 [patent_title] => 'Trehalulose-containing composition, its preparation and use' [patent_app_type] => utility [patent_app_number] => 13/263361 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 12485 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6502583 [patent_doc_number] => 20100260673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'PHAGE DISPLAY PEPTIDE PROBES FOR IMAGING EARLY RESPONSES TO ANTIANGIOGENIC TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/755009 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 15507 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260673.pdf [firstpage_image] =>[orig_patent_app_number] => 12755009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543153 [patent_doc_number] => 08318441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Fibrinogen alpha and hemoglobin polypeptides as cancer markers' [patent_app_type] => utility [patent_app_number] => 12/753527 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 11546 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12753527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363839 [patent_doc_number] => 08252900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Actriib-Fc polynucleotides, polypeptides, and compositions' [patent_app_type] => utility [patent_app_number] => 12/751868 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23253 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12751868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9126881 [patent_doc_number] => 08574829 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Methods of treating cancer with phenformin' [patent_app_type] => utility [patent_app_number] => 13/260838 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 12802 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13260838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10002446 [patent_doc_number] => 09046529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Prostatitis-associated antigens and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/262752 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 21879 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186880 [patent_doc_number] => 20120115928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'MIRNA AND ITS TARGETS RESPECTIVELY THE PROTEINS MADE BASED ON THE TARGETS AS A PROGNOSTIC, DIAGNOSTIC BIOMARKER AND THERAPEUTIC AGENT FOR CANCER' [patent_app_type] => utility [patent_app_number] => 13/260488 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6951 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115928.pdf [firstpage_image] =>[orig_patent_app_number] => 13260488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6516230 [patent_doc_number] => 20100216826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Polymorphisms in Voltage-Gated Sodium Channel Alpha 1-Subunit as Markers for Therapy Selection' [patent_app_type] => utility [patent_app_number] => 12/732985 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10073 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216826.pdf [firstpage_image] =>[orig_patent_app_number] => 12732985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533157 [patent_doc_number] => 08309311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Method for early detection of cancers' [patent_app_type] => utility [patent_app_number] => 12/730844 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7647 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12730844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8340324 [patent_doc_number] => 08242248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Kits for multiparametric phospho analysis' [patent_app_type] => utility [patent_app_number] => 12/730170 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33033 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12730170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8159123 [patent_doc_number] => 20120100561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'A PKN3/RHOC MACROMOLECULAR COMPLEX AND METHODS OF USE THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/256207 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9059 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100561.pdf [firstpage_image] =>[orig_patent_app_number] => 13256207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6632014 [patent_doc_number] => 20100173338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Biomarkers for Cancer Sensitivity and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/723113 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18423 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173338.pdf [firstpage_image] =>[orig_patent_app_number] => 12723113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6474622 [patent_doc_number] => 20100284920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'USES OF MONOCLONAL ANTIBODY 8H9' [patent_app_type] => utility [patent_app_number] => 12/721798 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 56278 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284920.pdf [firstpage_image] =>[orig_patent_app_number] => 12721798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6423945 [patent_doc_number] => 20100168028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'COMPOSITIONS AND METHODS OF USING CRMP-1 AND ITS FRAGMENTS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/718997 [patent_app_country] => US [patent_app_date] => 2010-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15569 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168028.pdf [firstpage_image] =>[orig_patent_app_number] => 12718997 [rel_patent_id] =>[rel_patent_doc_number] =>)